MedTrace Logo

Study on the Effect of Online Cognitive Training Doses on Cognitive Function in Individuals With Mild Cognitive Decline

NCT07213362 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 234

Last updated 2025-10-08

No results posted yet for this study

Summary

The primary questions that this clinical trial aims to answer are:

To compare the differences in the efficacy of different doses of Computerized Cognitive Training (CCT) in improving cognitive function among patients with Mild Cognitive Impairment (MCI), and to explore the potential optimal intervention dose.

To analyze the interaction between individual characteristics and the intervention dose of CCT.

To compare the improvement in functional activity ability of MCI patients among different CCT intervention dose groups.

To compare the symptoms of depression and anxiety among different CCT intervention dose groups.

To evaluate the adherence to different doses of CCT intervention.

Participants will:

Receive CCT intervention at varying durations and frequencies over a 12-week period, and will be followed up for cognitive function, functional activity ability, etc., at weeks 4, 12, and 24.

Conditions

  • Mild Cognitive Disorder

Interventions

DEVICE

Computerized Cognitive Training

Computerized Cognitive Training (30 minutes per session, 3 sessions per week, for a 12-week period)

DEVICE

Computerized Cognitive Training

Computerized Cognitive Training (45 minutes per session, 3 sessions per week, for a 12-week period)

DEVICE

Computerized Cognitive Training

Computerized Cognitive Training (60 minutes per session, 3 sessions per week, for a 12-week period)

DEVICE

Computerized Cognitive Training

Computerized Cognitive Training (30 minutes per session, 5 sessions per week, for a 12-week period)

DEVICE

Computerized Cognitive Training

Computerized Cognitive Training (45 minutes per session, 5 sessions per week, for a 12-week period)

DEVICE

Computerized Cognitive Training

Computerized Cognitive Training (60 minutes per session, 5 sessions per week, for a 12-week period)

Sponsors & Collaborators

  • Peking University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-08
Primary Completion
2026-06-30
Completion
2026-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07213362 on ClinicalTrials.gov